Total Payments
$7,364
2024 Payments
$1,931
Companies
18
Transactions
62
Medicare Patients
5,667
Medicare Billing
$481,799
Payment Breakdown by Category
Travel$5,746 (78.0%)
Food & Beverage$1,600 (21.7%)
Education$18.34 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $5,746 | 14 | 78.0% |
| Food and Beverage | $1,600 | 47 | 21.7% |
| Education | $18.34 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Penumbra, Inc. | $3,948 | 8 | $0 (2024) |
| Philips Electronics North America Corporation | $1,134 | 1 | $0 (2018) |
| Terumo Medical Corporation | $580.57 | 2 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $475.16 | 5 | $0 (2017) |
| Medtronic Vascular, Inc. | $339.01 | 4 | $0 (2019) |
| Siemens Medical Solutions USA, Inc. | $227.00 | 2 | $0 (2024) |
| Amgen Inc. | $95.75 | 4 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $91.43 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $88.52 | 6 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $86.85 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,931 | 8 | Penumbra, Inc. ($1,672) |
| 2023 | $10.03 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($10.03) |
| 2022 | $1,351 | 4 | Penumbra, Inc. ($1,331) |
| 2021 | $17.78 | 1 | Novo Nordisk Inc ($17.78) |
| 2020 | $62.89 | 3 | Janssen Pharmaceuticals, Inc ($44.06) |
| 2019 | $1,346 | 9 | Penumbra, Inc. ($944.32) |
| 2018 | $1,853 | 12 | Philips Electronics North America Corporation ($1,134) |
| 2017 | $793.30 | 24 | BOSTON SCIENTIFIC CORPORATION ($475.16) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $122.75 | General |
| Category: Peripheral Intervention | ||||||
| 09/27/2024 | Penumbra, Inc. | Indigo System (Device) | Travel and Lodging | Cash or cash equivalent | $858.06 | General |
| Category: Peripheral Intervention | ||||||
| 09/27/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $404.70 | General |
| Category: Peripheral Intervention | ||||||
| 09/20/2024 | Penumbra, Inc. | Indigo System (Device) | Travel and Lodging | Cash or cash equivalent | $286.95 | General |
| Category: Peripheral Intervention | ||||||
| 03/20/2024 | Siemens Medical Solutions USA, Inc. | — | Travel and Lodging | In-kind items and services | $49.00 | General |
| 03/18/2024 | Siemens Medical Solutions USA, Inc. | — | Travel and Lodging | In-kind items and services | $178.00 | General |
| 03/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/18/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2022 | Penumbra, Inc. | Indigo System (Device) | Travel and Lodging | Cash or cash equivalent | $705.74 | General |
| Category: Peripheral Intervention | ||||||
| 09/09/2022 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $330.01 | General |
| Category: Peripheral Intervention | ||||||
| 09/09/2022 | Penumbra, Inc. | Indigo System (Device) | Travel and Lodging | Cash or cash equivalent | $295.05 | General |
| Category: Peripheral Intervention | ||||||
| 12/16/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Diabetes | ||||||
| 12/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $18.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2019 | Penumbra, Inc. | Indigo (Device) | Travel and Lodging | Cash or cash equivalent | $944.32 | General |
| Category: Peripheral Intervention | ||||||
| 09/13/2019 | Medtronic Vascular, Inc. | HawkOne (Device) | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: Directional Atherectomy Devices | ||||||
| 09/12/2019 | Medtronic Vascular, Inc. | HawkOne (Device) | Travel and Lodging | In-kind items and services | $291.91 | General |
| Category: Directional Atherectomy Devices | ||||||
| 09/12/2019 | Medtronic Vascular, Inc. | HawkOne (Device) | Travel and Lodging | In-kind items and services | $30.67 | General |
| Category: Directional Atherectomy Devices | ||||||
| 09/11/2019 | Medtronic Vascular, Inc. | HawkOne (Device) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Directional Atherectomy Devices | ||||||
| 07/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Diabetes | ||||||
| 06/13/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,510 | 1,928 | $240,100 | $105,923 |
| 2022 | 15 | 1,203 | 1,582 | $211,409 | $92,602 |
| 2021 | 21 | 1,441 | 2,041 | $311,489 | $134,230 |
| 2020 | 18 | 1,513 | 2,240 | $336,265 | $149,044 |
Total Patients
5,667
Total Services
7,791
Medicare Billing
$481,799
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 444 | $55,710 | $29,759 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 196 | 280 | $27,090 | $17,285 | 63.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 87 | 172 | $24,940 | $10,841 | 43.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 89 | 91 | $18,746 | $9,222 | 49.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 170 | 172 | $30,272 | $8,149 | 26.9% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 42 | 42 | $27,132 | $6,568 | 24.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 35 | $6,720 | $3,319 | 49.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 44 | 79 | $6,241 | $3,149 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 32 | 32 | $5,020 | $2,712 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 48 | $5,226 | $2,553 | 48.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $4,536 | $1,935 | 42.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $3,163 | $1,617 | 51.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 23 | 23 | $4,692 | $1,320 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $1,916 | $1,308 | 68.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 178 | 202 | $4,242 | $1,259 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 24 | 26 | $1,786 | $1,194 | 66.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 60 | 61 | $3,111 | $959.90 | 30.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $2,100 | $800.52 | 38.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 60 | 61 | $2,135 | $637.42 | 29.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 20 | 20 | $1,460 | $351.69 | 24.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 16 | 18 | $1,080 | $313.12 | 29.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 20 | 20 | $1,240 | $274.17 | 22.1% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 12 | 12 | $960.00 | $244.32 | 25.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 23 | 23 | $483.00 | $129.20 | 26.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 11 | 11 | $99.00 | $24.00 | 24.2% |
About Dr. Athar Saeed, M.D
Dr. Athar Saeed, M.D is a Interventional Cardiology healthcare provider based in Morris, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1639348881.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Athar Saeed, M.D has received a total of $7,364 in payments from pharmaceutical and medical device companies, with $1,931 received in 2024. These payments were reported across 62 transactions from 18 companies. The most common payment nature is "Travel and Lodging" ($5,746).
As a Medicare-enrolled provider, Saeed has provided services to 5,667 Medicare beneficiaries, totaling 7,791 services with total Medicare billing of $481,799. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Nuclear Cardiology, Cardiovascular Disease
- Location Morris, IL
- Active Since 02/21/2008
- Last Updated 01/27/2026
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1639348881
Products in Payments
- Indigo System (Device) $3,003
- Image Guided Therapy Devices _ Coronary (Device) $1,134
- Indigo (Device) $944.32
- GENERAL - ATHERECTOMY (Device) $459.20
- HawkOne (Device) $339.01
- Corlanor (Drug) $95.75
- LifeVest (Device) $91.43
- ENTRESTO (Drug) $88.52
- XARELTO (Drug) $86.85
- VIAGRA (Drug) $53.78
- PRALUENT ALIROCUMAB INJECTION (Biological) $49.41
- ELIQUIS (Drug) $38.52
- FARXIGA (Drug) $37.24
- RYBELSUS (Drug) $17.78
- Peripheral Orbital Atherectomy System (Device) $16.54
- GENERAL - TACHY (Device) $15.96
- Victoza (Drug) $15.83
- TR Band (Device) $15.55
- LONHALA MAGNAIR (Drug) $15.34
- Ozempic (Drug) $14.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.